Skip to main content

Table 2 Changes in physiological variables induced by high-flow nasal cannula and noninvasive ventilation

From: High-flow nasal oxygen versus noninvasive ventilation in adult patients with cystic fibrosis: a randomized crossover physiological study

Variables

Baseline

NIV

HFNT

p

Baseline versus NIV

p

Baseline versus HFNT

p

NIV versus HFNT

Respiratory pattern

      

Respiratory rate (min−1)

21 (17–26)

19 (18–26)

18 (13–20)

0.99

0.01

0.13

Tidal volume (mL/kg)

5.4 (4.3–10.6)

5.6 (3.9–10.6)

5.6 (4.2–10.2)

0.49

0.49

0.02

Minute ventilation (L/min)

6.9 (5.3–11.5)

5.6 (5.0–8.4)

5.0 (4.2–6.6)

0.46

0.01

0.46

SpO2 (%)

93 (90–94)

93 (92–94)

94 (93–95)

0.99

0.30

0.51

Transcutaneous CO2 (mmHg)

53 (42–60)

53 (41–60)

54 (41–60)

0.99

0.98

0.99

Hemodynamic

      

Heart rate (min−1)

108 (89–114)

101 (92–115)

102 (91–114)

0.94

0.43

0.99

Mean arterial pressure (mmHg)

85 (78–91)

91 (81–101)

84 (77–94)

< 0.01

0.99

0.01

Diaphragm activity

      

Thickening fraction (%)

30 (25–46)

35 (23–41)

36 (19–41)

0.99

0.99

0.99

Symptoms

      

Dyspnea

1 (0–3)

1 (0–2)

1 (0–3)

0.82

0.99

0.99

Comfort

9 (8–10)

7 (6–9)

6 (5–8)

0.02

< 0.01

0.99

  1. Continuous variables are expressed as median (interquartile range). Devices are compared head to head, and each device is compared to baseline conditions using the Wilcoxon signed-ranks test.
  2. HFNT high-flow nasal therapy, NIV noninvasive ventilation, n = 15